Page last updated: 2024-09-05

organophosphonates and 3,4-dihydroxybenzohydroxamic acid

organophosphonates has been researched along with 3,4-dihydroxybenzohydroxamic acid in 1 studies

Compound Research Comparison

Studies (organophosphonates)	Trials (organophosphonates)	Recent Studies (post-2010) (organophosphonates)	Studies (3,4-dihydroxybenzohydroxamic acid)	Trials (3,4-dihydroxybenzohydroxamic acid)	Recent Studies (post-2010) (3,4-dihydroxybenzohydroxamic acid)
9,968	880	3,596	53	2	13

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pagano, JS; Raab-Traub, N; Wakisaka, N; Yoshizaki, T	1

Other Studies

1 other study(ies) available for organophosphonates and 3,4-dihydroxybenzohydroxamic acid

Article	Year
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts. International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme Inhibitors; Epstein-Barr Virus Infections; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Ribonucleotide Reductases; Transplantation, Heterologous; Tumor Cells, Cultured	2005

Article

Year

Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.

International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4

Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme Inhibitors; Epstein-Barr Virus Infections; Humans; Hydroxamic Acids; Hydroxyurea; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Organophosphonates; Ribonucleotide Reductases; Transplantation, Heterologous; Tumor Cells, Cultured

2005